Ontology highlight
ABSTRACT:
SUBMITTER: Li Y
PROVIDER: S-EPMC5290709 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Li Yan Y Qiu Wen W Zhang Lingjun L Fung John J Lin Feng F
Biomaterials 20160608
Mesenchymal stem cells (MSCs) are undergoing intensive testing in clinical trials as a promising new therapy for many inflammatory diseases and for regenerative medicine, but further optimization of current MSC-based therapies is required. In this study, we found that in addition to direct complement-mediated attack through the assembly of membrane attack complexes (MACs) that we and others have recently reported, of the released complement activation products, C5a, but not C3a, activates neutro ...[more]